Methotrexate for rheumatoid arthritis
53 results
1 - 53Methotrexate for treating rheumatoid arthritis
Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis
Methotrexate monotherapy versus methotrexate combination therapy with non‐biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis
Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A network meta‐analysis
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta‐analysis
Safety of non-steroidal anti-inflammatory drugs, including aspirin and paracetamol (acetaminophen) in people receiving methotrexate for inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease‐modifying anti‐rheumatic drugs: a systematic review and network meta‐analysis
Rituximab for rheumatoid arthritis: Cochrane systematic review
Adalimumab for treating rheumatoid arthritis
Infliximab for the treatment of rheumatoid arthritis
Penicillamine for treating rheumatoid arthritis
Golimumab for rheumatoid arthritis: Cochrane systematic review
Tocilizumab for rheumatoid arthritis: Cochrane systematic review
Certolizumab pegol (CDP870) for rheumatoid arthritis in adults
Etanercept for the treatment of rheumatoid arthritis: Cochrane systematic review
Auranofin versus placebo in rheumatoid arthritis
Methotrexate for psoriatic arthritis
Cyclophosphamide for treating rheumatoid arthritis
Biologics or tofacitinib for people with rheumatoid arthritis unsuccessfully treated with biologics: a systematic review and network meta-analysis
Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis): Cochrane systematic review
Leflunomide for the treatment of rheumatoid arthritis
Methotrexate for ankylosing spondylitis
Antidepressants for pain management in rheumatoid arthritis: Cochrane systematic review
Methotrexate for induction of remission in refractory Crohn's disease: Cochrane systematic review
Biologic or tofacitinib monotherapy for rheumatoid arthritis in people with traditional disease‐modifying anti‐rheumatic drug (DMARD) failure: a Cochrane Systematic Review and network meta‐analysis (NMA)